Risk factors for progressing to severe or critical COVID-19 illness clinical guideline

Version 3.0 approved 14 April 2022

Studies have demonstrated that the risk of severe COVID-19 increases with age and number of comorbidities. Supplies of medications from the National Medical Stockpile (NMS) can vary according to outbreaks and demand and in the setting of limited supply certain risk factors or patients with greater than 1 risk factor may be prioritised for treatment of mild disease.

See Risk factors for progressing to severe or critical COVID-19 illness clinical guideline (PDF 330KB) for further information including:

  • Background
  • Risk factors for progressing to severe or critical COVID-19 illness
  • Classification of Immunosuppressed Patients
  • Resources
  • References